Olr193 inhibitors represent a specialized category of chemical compounds designed to interact specifically with the Olr193 receptor, a member of the olfactory receptor family, which is part of the G protein-coupled receptor (GPCR) superfamily. These receptors are predominantly involved in the detection of odorants, playing a crucial role in the olfactory system by transducing chemical signals into neuronal responses that contribute to the perception of smells. Inhibitors of Olr193 are typically small molecules or peptides that bind to this receptor, altering its conformation and preventing it from interacting with its natural ligands, thereby modulating the signal transduction pathway. This modulation can be useful in research settings for investigating the specific olfactory pathways that are triggered by the activation or inhibition of Olr193, as well as for deciphering the broader roles of olfactory receptors in biological processes beyond olfaction.
From a chemical perspective, Olr193 inhibitors are designed with a focus on achieving high specificity and affinity for the Olr193 receptor, minimizing off-target effects that could interfere with other olfactory receptors or GPCRs. Structural studies, including computational modeling and crystallography, have been instrumental in guiding the design of these inhibitors. They often include functional groups that enhance their binding efficiency, such as hydrophobic moieties that interact with the receptor's transmembrane regions or polar groups that form hydrogen bonds with key amino acid residues within the receptor's binding pocket. The development of these inhibitors also involves optimizing their physicochemical properties, such as solubility and stability, to ensure that they maintain their efficacy under various experimental conditions. By fine-tuning these molecular characteristics, researchers aim to create highly effective tools for probing the specific functions of the Olr193 receptor in both isolated systems and more complex biological environments.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Xanthine oxidase inhibitor, affects purine metabolism, potentially influencing Olr193. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Beta-blocker with antioxidant properties, may modulate cardiac function, impacting Olr193. | ||||||
Diclofenac acid | 15307-86-5 | sc-357332 sc-357332A | 5 g 25 g | $109.00 $298.00 | 5 | |
NSAID, inhibits prostaglandin synthesis, might affect inflammatory pathways, impacting Olr193. | ||||||
Hydrochlorothiazide | 58-93-5 | sc-207738 sc-207738A sc-207738B sc-207738C sc-207738D | 5 g 25 g 50 g 100 g 250 g | $55.00 $240.00 $333.00 $562.00 $988.00 | ||
Thiazide diuretic, affects electrolyte balance, could influence renal pathways, impacting Olr193. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Antifungal, inhibits steroid synthesis, might affect hormone pathways, impacting Olr193. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Angiotensin II receptor blocker, may modulate cardiovascular function, potentially impacting Olr193. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Biguanide, influences glucose metabolism, could impact insulin signaling pathways, affecting Olr193. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Thiazolidinedione, PPAR gamma agonist, affects lipid metabolism, potentially influencing Olr193. | ||||||
Ranitidine | 66357-35-5 | sc-203679 | 1 g | $193.00 | ||
H2 receptor antagonist, affects gastric acid secretion, could influence digestive processes, impacting Olr193. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Statin, inhibits cholesterol synthesis, might affect lipid pathways, impacting Olr193. | ||||||